Enhancing the outcomes of diabetic vitrectomy with pharmacological adjuvants  

作　　者：Chun-Yao Cheng Wen-Rui Hao Tzu-Hurng Cheng 

机构地区：[1]Department of Ophthalmology,Cathay General Hospital,Taipei 10633,Taiwan,China [2]Division of Cardiology,Department of Internal Medicine,Shuang Ho Hospital,Ministry of Health and Welfare,Taipei Medical University,New Taipei City 23561,Taiwan,China [3]Division of Cardiology,Department of Internal Medicine,School of Medicine,College of Medicine,Taipei Medical University,Taipei 11002,Taiwan,China [4]Department of Biochemistry,School of Medicine,College of Medicine,China Medical University,Taichung City 404328,Taiwan,China

出　　处：《World Journal of Methodology》2025年第2期15-20,共6页世界方法学杂志（英文）

摘　　要：This editorial offers insights from a minireview by Venkatesh et al,who explored pharmacological adjuvants for diabetic vitrectomy.Specifically,they synthesized current knowledge and evaluated the efficacy of various adjunctive therapies in improving the outcomes of diabetic retinopathy and managing associated complications.Herein,we highlight the key roles of pharmacological adjuvants in optimizing surgical techniques,minimizing intraoperative challenges,and enhancing postoperative recovery.We further discuss the potential implications of this approach for clinical practice and future research directions in this evolving field.Overall,this editorial underscores the importance of incorporating pharmacological adjuvants into standard diabetic vitrectomy care to improve surgical outcomes and thus patients’quality of life.

关 键 词：Diabetic vitrectomy Pharmacological adjuvants Surgical outcomes Diabetic retinopathy Clinical implications 

分 类 号：R473.5[医药卫生—护理学]